Celldex Therapeutics shares are trading lower after the company announced a proposed public offering of 7.425 million shares at $27 per share.
Portfolio Pulse from Benzinga Newsdesk
Celldex Therapeutics announced a proposed public offering of 7.425 million shares at $27 per share, causing its shares to trade lower.
November 08, 2023 | 6:06 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Celldex Therapeutics' stock price is trading lower due to the announcement of a public offering of 7.425 million shares at $27 per share.
The announcement of a public offering often leads to a decrease in the stock price as it dilutes the value of existing shares. In this case, Celldex Therapeutics' shares are trading lower following the announcement of a public offering of 7.425 million shares at $27 per share.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100